HSGX Histogenics Corporation

Danforth Advisors, LLC, a consulting firm providing operational accounting and finance support, together with CFO services, for private and public life science companies, today announced the appointment of Jonathan Lieber as Managing Director. With over 25 years of life science experience as a CFO and investment banker, Jon brings deep expertise to the role in service of clients at all stages of growth.

“We hold ourselves to the highest standards of talent in the business, and Jon is no exception. We are thrilled to have him on board as we continue to grow and partner with some of today’s most exciting life science companies,” said Gregg Beloff, Founding Managing Director, Danforth Advisors.

“Having known the Danforth team for many years, I’ve seen firsthand the quality of their work and the value they offer to both start-ups and mature companies,” said Jon. “I look forward to engaging with a variety of clients as both a finance team leader and strategic partner for the management teams and boards with whom I will be working.”     

Jon’s background includes financial and executive management roles at emerging and growth-stage life science companies. As a CFO, he has raised more than $300 million of equity and debt in public and private securities offerings, including a $110 million IPO at Altus Pharmaceuticals, and led strategic and business development transactions including the successful sale of Xcellerex to GE Healthcare. He most recently served as CFO of Histogenics (NASDAQ: HSGX), a publicly-traded cell therapy company developing products for the orthopedics market. He additionally held the roles of CFO for Metamark Genetics and CFO and Treasurer of Repligen.

Previously, Jon was an investment banker for ten years at Cowen and Salomon Brothers, during which time he originated and executed on numerous corporate financings and merger and acquisition transactions. He received a BS in business administration and finance from Boston University and an MBA in finance from New York University Stern School of Business.

About Danforth Advisors Danforth is the financial backbone to hundreds of life science companies, providing integrated and scalable consulting teams ranging from controller through CFO. The company’s services span the full breadth of a finance organization’s needs, whether short or long term, including accounting and operational finance support, capital raising, financial planning and analysis, IPO preparation and post-public SEC compliance. Founded in 2011, Danforth has been a strategic and trusted thought partner to over 350 life science companies, private and public, across all stages of the corporate life cycle. The company is headquartered in Boston, Massachusetts with additional operations in the emerging life science clusters of metropolitan New York, Philadelphia, Pittsburgh, Colorado and Texas. Additional information is available at www.danforthadvisors.com.

Media Contact:
Felicia Krupps
617-418-9434
fkrupps@danforthadvisors.com